Search results
5 days ago · How we approach editorial content. Review quarterly and annual revenue, net income, and cash flow for Eli Lilly and Co (LLY:XNYS) stock through the last fiscal year.
5 days ago · Headquarters. Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 39,000 full-time employees. The firm discovers, develops, manufactures and markets products in the human pharmaceutical products segment.
4 days ago · CIALIS® (tadalafil), an oral treatment for erectile dysfunction, is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Tadalafil has the empirical formula C22H19N3O4 representing a molecular weight of 389.41. The structural formula is:
2 days ago · How much institutional selling is happening at Eli Lilly and Company? Institutional investors have sold a total of 133,228,404 shares in the last 24 months. This volume of shares sold represents approximately $61.05B in transactions. This page (NYSE:LLY) was last updated on 7/1/2024 by MarketBeat.com Staff.
2 days ago · 19 Wall Street research analysts have issued 1 year price objectives for Eli Lilly and Company's shares. Their LLY share price targets range from $535.00 to $1,015.00. On average, they anticipate the company's share price to reach $812.72 in the next year. This suggests that the stock has a possible downside of 10.4%.
5 days ago · Currently, Eli Lilly And Co’s price-earnings ratio is 133.8. Eli Lilly And Co’s trailing 12-month revenue is $35.9 billion with a 17.1% net profit margin. Year-over-year quarterly sales growth most recently was 26.0%. Analysts expect adjusted earnings to reach $13.772 per share for the current fiscal year.
3 days ago · As of today (2024-06-30), Eli Lilly and Co 's share price is $905.38. Eli Lilly and Co 's GF Value is $441.87. Therefore, Eli Lilly and Co 's Price-to-GF-Value for today is 2.05. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Eli Lilly and Co is Significantly Overvalued.
